鲁抗医药

- 600789

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
鲁抗医药(600789) 利润表
单位:万元
报表日期2026-03-312025-12-312025-09-302025-06-302025-03-31
一、营业总收入161,644.55576,611.55462,435.04315,399.36167,369.96
营业收入161,644.55576,611.55462,435.04315,399.36167,369.96
二、营业总成本154,048.85561,818.24442,840.39297,294.19160,357.60
营业成本127,192.38449,327.03362,025.17244,481.52132,718.98
营业税金及附加1,221.885,773.964,100.772,755.811,241.41
销售费用10,626.7245,436.3832,121.4721,634.5411,738.05
管理费用6,362.2325,655.3018,711.3312,408.096,370.74
财务费用2,214.055,710.723,792.612,195.811,404.72
研发费用6,431.6029,914.8522,089.0513,818.436,883.69
资产减值损失----------
公允价值变动收益---7.13-7.13-7.13--
投资收益-120.68-522.04-311.08-208.37-129.86
其中:对联营企业和合营企业的投资收益-120.90-532.04-321.08-217.49-129.86
汇兑收益----------
三、营业利润6,613.2616,057.2019,033.1414,692.378,586.17
加:营业外收入116.55532.2646.5318.6416.88
减:营业外支出55.89468.76446.06417.780.09
其中:非流动资产处置损失----------
四、利润总额6,673.9116,120.7118,633.6114,293.238,602.96
减:所得税费用1,020.474,930.083,971.683,228.41368.06
五、净利润5,653.4411,190.6414,661.9211,064.828,234.90
归属于母公司所有者的净利润5,325.3411,230.4814,119.6210,683.507,859.76
少数股东损益328.10-39.85542.30381.32375.13
六、每股收益
基本每股收益(元/股)0.05000.12000.16000.12000.0900
稀释每股收益(元/股)0.05000.12000.16000.12000.0900
七、其他综合收益-45.43-241.37-198.63-138.72-130.62
八、综合收益总额5,608.0110,949.2614,463.3010,926.108,104.28
归属于母公司所有者的综合收益总额5,279.9110,989.1113,920.9910,544.787,729.15
归属于少数股东的综合收益总额328.10-39.85542.30381.32375.13
下载全部历史数据到excel中 返回页顶